469 related articles for article (PubMed ID: 17825280)
1. Desensitization and re-sensitization of CGRP receptor function in human neuroblastoma SK-N-MC cells.
Pin SS; Xu C; Bahr BA
Eur J Pharmacol; 2007 Dec; 577(1-3):7-16. PubMed ID: 17825280
[TBL] [Abstract][Full Text] [Related]
2. Desensitization of adrenomedullin and calcitonin gene-related peptide receptors in vascular smooth muscle cells--effects of receptor activity-modifying protein.
Qi YF; Xue L; Chai SB; Shi YR; Pang YZ; Tang CS
Sheng Li Xue Bao; 2001 Oct; 53(5):396-400. PubMed ID: 11833426
[TBL] [Abstract][Full Text] [Related]
3. Volatile anesthetics inhibit calcitonin gene-related peptide receptor-mediated responses in pithed rats and human neuroblastoma cells.
Kuroda M; Yoshikawa D; Nishikawa K; Saito S; Goto F
J Pharmacol Exp Ther; 2004 Dec; 311(3):1016-22. PubMed ID: 15297469
[TBL] [Abstract][Full Text] [Related]
4. Protein kinase C is a common component of CGRP receptor desensitization induced by distinct agonists.
Pin SS; Bahr BA
Eur J Pharmacol; 2008 Jun; 587(1-3):8-15. PubMed ID: 18420188
[TBL] [Abstract][Full Text] [Related]
5. Cys2,7EtalphaCGRP is a potent agonist for CGRP1 receptors in SK-N-MC cells.
Nodin C; Vauquelin G; von Mentzer B
Biochem Pharmacol; 2005 Apr; 69(8):1235-40. PubMed ID: 15794944
[TBL] [Abstract][Full Text] [Related]
6. Effects of adrenomedullin on cyclic AMP formation and on relaxation in iris sphincter smooth muscle.
Yousufzai SY; Ali N; Abdel-Latif AA
Invest Ophthalmol Vis Sci; 1999 Dec; 40(13):3245-53. PubMed ID: 10586949
[TBL] [Abstract][Full Text] [Related]
7. The vasorelaxant effect of adrenomedullin, proadrenomedullin N-terminal 20 peptide and amylin in human skin.
Hasbak P; Eskesen K; Lind H; Holst J; Edvinsson L
Basic Clin Pharmacol Toxicol; 2006 Aug; 99(2):162-7. PubMed ID: 16918718
[TBL] [Abstract][Full Text] [Related]
8. Adrenomedullin and CGRP interact with endogenous calcitonin-receptor-like receptor in endothelial cells and induce its desensitisation by different mechanisms.
Nikitenko LL; Blucher N; Fox SB; Bicknell R; Smith DM; Rees MC
J Cell Sci; 2006 Mar; 119(Pt 5):910-22. PubMed ID: 16495482
[TBL] [Abstract][Full Text] [Related]
9. Stimulation of adenylate cyclase by amylin in CHO-K1 cells.
D'Santos CS; Gatti A; Poyner DR; Hanley MR
Mol Pharmacol; 1992 May; 41(5):894-9. PubMed ID: 1375316
[TBL] [Abstract][Full Text] [Related]
10. Investigation of CGRP receptors and peptide pharmacology in human coronary arteries. Characterization with a nonpeptide antagonist.
Hasbak P; Saetrum Opgaard O; Eskesen K; Schifter S; Arendrup H; Longmore J; Edvinsson L
J Pharmacol Exp Ther; 2003 Jan; 304(1):326-33. PubMed ID: 12490608
[TBL] [Abstract][Full Text] [Related]
11. From micromolar to nanomolar affinity: a systematic approach to identify the binding site of CGRP at the human calcitonin gene-related peptide 1 receptor.
Rist B; Entzeroth M; Beck-Sickinger AG
J Med Chem; 1998 Jan; 41(1):117-23. PubMed ID: 9438028
[TBL] [Abstract][Full Text] [Related]
12. Desensitization of CGRP and adrenomedullin receptors in SK-N-MC cells: implications for the RAMP hypothesis.
Drake WM; Ajayi A; Lowe SR; Mirtella A; Bartlett TJ; Clark AJ
Endocrinology; 1999 Jan; 140(1):533-7. PubMed ID: 9886866
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological characterization of novel alpha-Calcitonin Gene-Related Peptide (CGRP) receptor peptide antagonists that are selective for human CGRP receptors.
Taylor CK; Smith DD; Hulce M; Abel PW
J Pharmacol Exp Ther; 2006 Nov; 319(2):749-57. PubMed ID: 16873605
[TBL] [Abstract][Full Text] [Related]
14. The role of peptides and receptors of the calcitonin family in the regulation of bone metabolism.
Naot D; Cornish J
Bone; 2008 Nov; 43(5):813-8. PubMed ID: 18687416
[TBL] [Abstract][Full Text] [Related]
15. Identification of N-terminal receptor activity-modifying protein residues important for calcitonin gene-related peptide, adrenomedullin, and amylin receptor function.
Qi T; Christopoulos G; Bailey RJ; Christopoulos A; Sexton PM; Hay DL
Mol Pharmacol; 2008 Oct; 74(4):1059-71. PubMed ID: 18593822
[TBL] [Abstract][Full Text] [Related]
16. Characterization of calcitonin gene-related peptide (CGRP) receptors in intramural coronary arteries from male and female Sprague Dawley rats.
Sheykhzade M; Nyborg NC
Br J Pharmacol; 1998 Apr; 123(7):1464-70. PubMed ID: 9579744
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological characterization of CGRP receptors mediating relaxation of the rat pulmonary artery and inhibition of twitch responses of the rat vas deferens.
Wisskirchen FM; Burt RP; Marshall I
Br J Pharmacol; 1998 Apr; 123(8):1673-83. PubMed ID: 9605575
[TBL] [Abstract][Full Text] [Related]
18. CGRP receptors mediating CGRP-, adrenomedullin- and amylin-induced relaxation in porcine coronary arteries. Characterization with 'Compound 1' (WO98/11128), a non-peptide antagonist.
Hasbak P; Sams A; Schifter S; Longmore J; Edvinsson L
Br J Pharmacol; 2001 Aug; 133(8):1405-13. PubMed ID: 11498528
[TBL] [Abstract][Full Text] [Related]
19. Vasodilator responses to calcitonin gene-related peptide (CGRP) and amylin in the rat isolated perfused kidney are mediated via CGRP1 receptors.
Chin SY; Hall JM; Brain SD; Morton IK
J Pharmacol Exp Ther; 1994 Jun; 269(3):989-92. PubMed ID: 8014885
[TBL] [Abstract][Full Text] [Related]
20. Identification of an orphan receptor gene as a type 1 calcitonin gene-related peptide receptor.
Kapas S; Clark AJ
Biochem Biophys Res Commun; 1995 Dec; 217(3):832-8. PubMed ID: 8554605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]